The role of hypnotherapy for the treatment of inflammatory bowel diseases
The role of hypnotherapy for the treatment of inflammatory bowel diseases
复制标题
DOI：
10.1586/17474124.2014.917955
复制
发表时间：
2014-08-01
影响因子：
3.9
通讯作者：
Moser, Gabriele
中科院分区：
文献类型：
--
作者：
Moser, Gabriele
炎症性肠病(IBD)是一种病因不明的慢性疾病，以病情加重和缓解为特征。有证据表明，知觉到的痛苦有助于IBD症状的爆发；焦虑和抑郁经常出现在活动期疾病的患者中。由于无法治愈，治疗必须侧重于预防并发症、诱导/维持缓解和改善生活质量。肠导催眠疗法(GHT)已成功应用于功能性胃肠道疾病。针对IBD的实验研究和病例报告很少发表；GHT提高了与健康相关的生活质量，并减轻了症状。此外，GHT似乎具有免疫调节作用，能够增加静止期溃疡性结肠炎患者的临床缓解。
Inflammatory bowel diseases (IBD) are chronic disorders of unknown aetiology which are characterized by episodes of exacerbations and remissions. There is evidence that perceived distress contributes to IBD symptom flares; anxiety and depression are frequently found in patients with the active disease. Because there is no cure, treatment has to focus on prevention of complications, induction/maintenance of remission and improvement of quality of life. Gut-directed hypnotherapy (GHT) has been used successfully in functional gastrointestinal disorders. Few experimental studies and case reports have been published for IBD; GHT increases the health-related quality of life and reduces symptoms. Additionally, GHT seems to have an immune-modulating effect and is able to augment clinical remission in patients with quiescent ulcerative colitis.